Krystal Biotech Inc.
KRYS | NASDAQ
$333.85
-$2.82 (-0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$333.85
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 389.13M | 290.52M | 50.7M | n/a | n/a | n/a |
Cost of Revenue | 28.77M | 20.06M | 3.09M | n/a | n/a | 1.85M |
Gross Profit | 360.36M | 270.45M | 47.61M | n/a | n/a | -1.85M |
Operating Income | 161.3M | 65.7M | -109.73M | -145.2M | -68.28M | -33M |
Interest Income | 28.18M | 29.66M | 22.62M | 5.22M | 197K | 832K |
Pretax Income | 189.47M | 95.36M | 12.9M | -139.98M | -69.57M | -32.17M |
Net Income | 204.83M | 89.16M | 10.93M | -139.98M | -69.57M | -32.17M |
Selling & General & Admin | 146.74M | 113.69M | 98.4M | 77.74M | 40.39M | 13.21M |
Research & Development | 58.05M | 53.57M | 46.43M | 42.46M | 27.88M | 17.94M |
Other Expenses | -5.72M | 37.5M | 12.5M | 25M | n/a | n/a |
Operating Expenses | 199.06M | 204.76M | 157.33M | 145.2M | 68.28M | 31.15M |
Interest Expense | n/a | n/a | n/a | n/a | 1.49M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 227.84M | 224.82M | 160.43M | 145.2M | 68.28M | 33M |
Income Tax Expense | -15.36M | 6.2M | 1.97M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 28.94M | 28.59M | 27.15M | 25.49M | 22.2M | 18.79M |
Shares Outstanding (Diluted) | 29.95M | 29.74M | 27.75M | 25.49M | 22.2M | 18.79M |
EPS (Basic) | 7.08 | 3.12 | 0.40 | -5.49 | -3.13 | -1.71 |
EPS (Diluted) | 6.84 | 3 | 0.39 | -5.49 | -3.13 | -1.71 |
EBITDA | 196.02M | 109.91M | -91.32M | -116.81M | -66.23M | -30.32M |
EBIT | 189.47M | 103.2M | -97.23M | -120.2M | -68.08M | -32.17M |
Depreciation & Amortization | 6.55M | 6.71M | 5.91M | 3.39M | 1.85M | 1.85M |
Add to Watchlist
Select watchlists to add or remove KRYS